302 related articles for article (PubMed ID: 28975561)
1. Liver transarterial embolizations in metastatic neuroendocrine tumors.
de Mestier L; Zappa M; Hentic O; Vilgrain V; Ruszniewski P
Rev Endocr Metab Disord; 2017 Dec; 18(4):459-471. PubMed ID: 28975561
[TBL] [Abstract][Full Text] [Related]
2. Transarterial embolization (TAE) is equally effective and slightly safer than transarterial chemoembolization (TACE) to manage liver metastases in neuroendocrine tumors.
Fiore F; Del Prete M; Franco R; Marotta V; Ramundo V; Marciello F; Di Sarno A; Carratù AC; de Luca di Roseto C; Colao A; Faggiano A
Endocrine; 2014 Sep; 47(1):177-82. PubMed ID: 24385266
[TBL] [Abstract][Full Text] [Related]
3. Hepatic intra-arterial therapies in metastatic neuroendocrine tumors: lessons from clinical practice.
Grozinsky-Glasberg S; Kaltsas G; Kaltsatou M; Lev-Cohain N; Klimov A; Vergadis V; Uri I; Bloom AI; Gross DJ
Endocrine; 2018 Jun; 60(3):499-509. PubMed ID: 29383678
[TBL] [Abstract][Full Text] [Related]
4. Transarterial liver-directed therapies of neuroendocrine hepatic metastases.
Nazario J; Gupta S
Semin Oncol; 2010 Apr; 37(2):118-26. PubMed ID: 20494704
[TBL] [Abstract][Full Text] [Related]
5. Role of hepatic intra-arterial therapies in metastatic neuroendocrine tumours (NET): guidelines from the NET-Liver-Metastases Consensus Conference.
Kennedy A; Bester L; Salem R; Sharma RA; Parks RW; Ruszniewski P;
HPB (Oxford); 2015 Jan; 17(1):29-37. PubMed ID: 25186181
[TBL] [Abstract][Full Text] [Related]
6. Outcomes After Transarterial Embolization of Neuroendocrine Tumor Liver Metastases Using Spherical Particles of Different Sizes.
Zener R; Yoon H; Ziv E; Covey A; Brown KT; Sofocleous CT; Thornton RH; Boas FE
Cardiovasc Intervent Radiol; 2019 Apr; 42(4):569-576. PubMed ID: 30627774
[TBL] [Abstract][Full Text] [Related]
7. Transarterial Chemoembolization vs Radioembolization for Neuroendocrine Liver Metastases: A Multi-Institutional Analysis.
Egger ME; Armstrong E; Martin RC; Scoggins CR; Philips P; Shah M; Konda B; Dillhoff M; Pawlik TM; Cloyd JM
J Am Coll Surg; 2020 Apr; 230(4):363-370. PubMed ID: 32032719
[TBL] [Abstract][Full Text] [Related]
8. GEP-NETS update: Interventional radiology: role in the treatment of liver metastases from GEP-NETs.
de Baere T; Deschamps F; Tselikas L; Ducreux M; Planchard D; Pearson E; Berdelou A; Leboulleux S; Elias D; Baudin E
Eur J Endocrinol; 2015 Apr; 172(4):R151-66. PubMed ID: 25385817
[TBL] [Abstract][Full Text] [Related]
9. [Arterial embolization of hepatic metastases from neuroendocrine tumors].
Libicher M; Bovenschulte H
Radiologe; 2009 Mar; 49(3):233-41. PubMed ID: 19183927
[TBL] [Abstract][Full Text] [Related]
10. Embolotherapy for Neuroendocrine Tumor Liver Metastases: Prognostic Factors for Hepatic Progression-Free Survival and Overall Survival.
Chen JX; Rose S; White SB; El-Haddad G; Fidelman N; Yarmohammadi H; Hwang W; Sze DY; Kothary N; Stashek K; Wileyto EP; Salem R; Metz DC; Soulen MC
Cardiovasc Intervent Radiol; 2017 Jan; 40(1):69-80. PubMed ID: 27738818
[TBL] [Abstract][Full Text] [Related]
11. Comparison of transarterial liver-directed therapies for low-grade metastatic neuroendocrine tumors in a single institution.
Engelman ES; Leon-Ferre R; Naraev BG; Sharma N; Sun S; O'Dorisio TM; Howe J; Button A; Zamba G; Halfdanarson TR
Pancreas; 2014 Mar; 43(2):219-25. PubMed ID: 24518499
[TBL] [Abstract][Full Text] [Related]
12. Hepatic artery embolization in advanced neuroendocrine tumors: Efficacy and long-term outcomes.
Pericleous M; Caplin ME; Tsochatzis E; Yu D; Morgan-Rowe L; Toumpanakis C
Asia Pac J Clin Oncol; 2016 Mar; 12(1):61-9. PubMed ID: 26663886
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases of neuroendocrine carcinomas: interventional treatment via transarterial embolization, chemoembolization and thermal ablation.
Vogl TJ; Naguib NN; Zangos S; Eichler K; Hedayati A; Nour-Eldin NE
Eur J Radiol; 2009 Dec; 72(3):517-28. PubMed ID: 18829195
[TBL] [Abstract][Full Text] [Related]
14. [Chemoperfusion and embolization in the treatment of liver metastases].
Vogl TJ; Mack MG; Eichler K; Zangos S; Naguib NN; Gruber-Rouh T
Rofo; 2011 Jan; 183(1):12-23. PubMed ID: 21113865
[TBL] [Abstract][Full Text] [Related]
15. Liver-Directed Therapies for Neuroendocrine Neoplasms.
Clift AK; Frilling A
Curr Oncol Rep; 2021 Mar; 23(4):44. PubMed ID: 33721122
[TBL] [Abstract][Full Text] [Related]
16. The Role of Interventional Radiology for the Treatment of Hepatic Metastases from Neuroendocrine Tumor: An Updated Review.
Barat M; Cottereau AS; Kedra A; Dermine S; Palmieri LJ; Coriat R; Dautry R; Tselikas L; Soyer P; Dohan A
J Clin Med; 2020 Jul; 9(7):. PubMed ID: 32698459
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic strategies for neuroendocrine liver metastases.
Frilling A; Clift AK
Cancer; 2015 Apr; 121(8):1172-86. PubMed ID: 25274401
[TBL] [Abstract][Full Text] [Related]
18. [Transcatheter arterial chemoembolization (TACE) using degradable starch microspheres (DSM) (DSM-TACE) for primary and metastatic liver neuroendocrine tumors from gastrointestinal neuroendocrine tumors].
Fujisaki T; Ikari T; Kamei A; Takano K; Kuraoka K; Yoshimoto K; Hirasawa T; Asahara S
Nihon Shokakibyo Gakkai Zasshi; 2008 Feb; 105(2):206-13. PubMed ID: 18250591
[TBL] [Abstract][Full Text] [Related]
19. Long-term survival analysis in combined transarterial embolization and stereotactic body radiation therapy versus stereotactic body radiation monotherapy for unresectable hepatocellular carcinoma >5 cm.
Su TS; Lu HZ; Cheng T; Zhou Y; Huang Y; Gao YC; Tang MY; Jiang HY; Lian ZP; Hou EC; Liang P
BMC Cancer; 2016 Nov; 16(1):834. PubMed ID: 27809890
[TBL] [Abstract][Full Text] [Related]
20. Role of interventional radiology in the treatment of patients with neuroendocrine metastases in the liver.
Kvols LK; Turaga KK; Strosberg J; Choi J
J Natl Compr Canc Netw; 2009 Jul; 7(7):765-72. PubMed ID: 19635229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
